Kingfa Science & Technology (India) Ltd-$ Q1 FY27 Results

Kingfa Science & Technology (India) reported standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations of ₹688.57 Cr, up 49.1% YoY from ₹461.93 Cr and up 19.0% QoQ from ₹578.47 Cr. Standalone net profit came in at ₹80.21 Cr, up 101.6% YoY from ₹39.79 Cr and up 35.6% QoQ from ₹59.15 Cr, with basic EPS at ₹59.19 versus ₹32.86 a year ago (+80.1%). PAT growing faster than revenue on both a YoY and QoQ basis is the core signal — this is a margin-expansion quarter, not just a volume story.

The expansion sits on operating leverage rather than a one-off: cost of materials consumed rose 48.4% YoY (₹476.76 Cr vs ₹321.48 Cr), tracking revenue almost one-for-one, but employee benefits expense grew only 21.8% YoY (₹11.36 Cr vs ₹9.33 Cr) and other expenses rose 34.0% YoY (₹47.95 Cr vs ₹35.79 Cr) — both well below the topline growth rate. That gap lifted operating margin to roughly 16.1% from about 12.5% a year ago (+~360 bps) and net margin to roughly 11.6% from 8.55% (+~300 bps). No exceptional items appear in either period, so the growth is unadjusted and clean.

The stock went into the print at ₹5,870, up 15.1% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters.

Management has issued no formal quarterly guidance on record, and the filing carries no separate press-release commentary beyond the standard SEBI board-outcome disclosure, so there is no company framing to reconcile against. On the street side, no quarter-specific consensus estimate for Q1 FY27 could be found; the closest available reference is analyst commentary (Univest) projecting roughly 15-20% full-year FY27 PAT growth — this quarter's 101.6% YoY PAT print runs well ahead of that annual pace, which reads as a beat relative to the implied run-rate, though it is not a like-for-like quarterly estimate. The results were approved the same day the Board also recommended a final dividend of ₹20 per equity share (face value ₹10) for FY26, with a record date of September 21, 2026, and executed a sweeping leadership transition: Wang Dazhong takes over as Chairman & Managing Director from August 15, 2026 in place of Bo Jingen (who resigned), Xie Dongming returns as CFO in place of Chen Xiaoqiong, Sethuraman Shanmugasundaram becomes Whole-time Director/COO, and new CTO (He Liuwei) and CMO (Saravanan Balasundaram) appointments were also made.